Etid klinik pou Dyabèt nan Nebraska
4 etid pou Dyabèt ap chèche patisipan nan sit nan Nebraska.
Tèks ofisyèl etid la (Anglè)
A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity
- University Of Nebraska Medical Center, Omaha
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 28, 2026 · NCT07595549Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
- GSR Enterprises, Inc., Lincoln
- Great Plains Health - Nephrology, North Platte
Ap rekriteFaz 2/3
Laj 18 ak plis · Tout sèks · Mizajou Sep 21, 2026 · NCT05485961Efficacy and Safety of Ribupatide Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes
- Kailera Clinical Site, Lincoln
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 3, 2026 · NCT07284901Empagliflozin Treatment in Kidney Transplant Recipients
- Omaha VA Nebraska-Western Iowa Health Care System, Omaha, NE, Omaha
Ap rekriteFaz 4
Laj 19 ak plis · Tout sèks · Mizajou Apr 21, 2026 · NCT06013865Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.